Kynurenine in cerebrospinal fluid as a biomarker in differential diagnosis of multiple sclerosis

被引：0
|
作者：
Suehs, K. -W. [1 ]
Novoselova, N. [2 ]
Kuhn, M. [2 ]
Kaever, V. [1 ]
Mueller-Vahl, K. [1 ]
Trebst, C. [1 ]
Skripuletz, T. [1 ]
Stangel, M. [3 ]
Pessler, F. [2 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Twincore Ctr Expt & Clin Infect Res, Hannover, Germany
[3] Hacettepe Univ, Hannover, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P724
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [21] Cerebrospinal fluid in Multiple Sclerosis
    Arasa, F.
    FORTSCHRITTE DER NEUROLOGIE UND PSYCHIATRIE UND IHRER GRENZGEBIETE, 1950, 18 (02): : 85 - 105
  • [22] The cerebrospinal fluid in multiple sclerosis
    Moore, JE
    ARCHIVES OF INTERNAL MEDICINE, 1920, 25 (01) : 58 - 62
  • [23] MULTIPLE SCLEROSIS AND CEREBROSPINAL FLUID
    TOURTELLOTTE, WW
    MEDICAL CLINICS OF NORTH AMERICA, 1963, 47 (06) : 1619 - &
  • [24] THE CEREBROSPINAL FLUID IN MULTIPLE SCLEROSIS
    FREEDMAN, DA
    MERRITT, HH
    RESEARCH PUBLICATIONS-ASSOCIATION FOR RESEARCH IN NERVOUS AND MENTAL DISEASE, 1948, 28 : 428 - 439
  • [25] Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
    Rajda, Cecilia
    Galla, Zsolt
    Polyak, Helga
    Maroti, Zoltan
    Babarczy, Kristof
    Pukoli, Daniel
    Vecsei, Laszlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [26] Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
    Harald Hegen
    Klaus Berek
    Florian Deisenhammer
    Wiener Medizinische Wochenschrift, 2022, 172 : 337 - 345
  • [27] Differential diagnosis of multiple sclerosis and connective tissue diseases according to serological tests and cerebrospinal fluid analysis
    Jacobi, C.
    Korporal, M.
    Wildemann, B.
    MULTIPLE SCLEROSIS, 2006, 12 : S22 - S22
  • [28] Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis
    Harris, Violaine K.
    Diamanduros, Andrew
    Good, Pamela
    Zakin, Elina
    Chalivendra, Varun
    Sadiq, Saud A.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 331 - 339
  • [29] Cerebrospinal fluid amyloid-β as potential biomarker for cognitive functioning in multiple sclerosis
    Van Dam, M.
    Willemse, E.
    Nauta, I.
    Huiskamp, M.
    Klein, M.
    Moraal, B.
    Geurts, J.
    Uitdehaag, B.
    Teunissen, C.
    De Jong, B.
    Hulst, H.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 495 - 496
  • [30] Circulating miR-150 in cerebrospinal fluid is a novel biomarker for multiple sclerosis
    Bergman, P.
    Piket, E.
    Khademi, M.
    James, T.
    Linden, M.
    Kockum, I.
    Brundin, L.
    Piehl, F.
    Olsson, T.
    Jagodic, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 633 - 633
12345